Prognostic Model of Hypertension
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 50,000
- 试验地点
- 1
- 主要终点
- Resistant hypertension
研究概览
简要总结
The aim of this study was to establish a registration and monitoring system for hypertension in Xinjiang from 2020 to 2030 to obtain real information about patient basic information, patient characteristics, diagnostic test patterns, treatment options, and hospitalization outcomes (including mortality). Treatment complications, hospitalization costs, and end-of-life events (death, major adverse cardiac events, mild adverse cardiovascular events) in patients with hypertension in Xinjiang; and scientific prevention strategies aimed at effectively preventing the onset of hypertension; Guidelines in clinical practice recommend, analyze and develop effective treatment strategies to optimize management and outcomes for patients with hypertension; and create cost-effective assessment systems.
详细描述
The aim of the study is to establish a platform for monitoring, clinical research and translational medicine in Xinjiang, which aims to provide a basis for future quality improvement and research, and to promote efforts to improve the prognosis of patients with hypertension, and to translate research into improved care for patients, thereby reducing Morbidity and mortality associated with hypertension.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •A patient diagnosed with primary hypertension who was admitted to the First Affiliated Hospital of Xinjiang Medical University
排除标准
- •Patients with secondary hypertension, patients with liver and kidney dysfunction,
- •patients with mental disorders, and patients who are unwilling to participate in this trial
结局指标
主要结局
Resistant hypertension
时间窗: 10 years of follow-up Resistant hypertension occurred during this period
Death (all-cause mortality, mortality from hypertension complications)
时间窗: 10 years of follow-up deaths occurred during this period
次要结局
- Major adverse cardiovascular events(10 years of follow-up deaths occurred during this period)
研究者
Xiang Xie
Xiangxie, MD,The First Affiliated Hospital Of XinJiang Medicial University
Xinjiang Medical University